In this study, we demonstrated that significantly reduced levels of CD3+T cells, CD4+T cells, CD8+T cells, DNT cells, NK cells, CD4+/CD8+ ratio, and LMR were detected in the peripheral blood of patients with breast cancer relative to patients with benign breast lesions. The gene discussed is CD4; the disease is breast carcinoma.